Clinical Trial Update: Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a Rebeccamycin analog in patients with metastatic or locally recurrent colorectal cancer has completed. The update does not incl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Rebeccamycin analog (rebeccamycin analog)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED